MedTrace Logo

Canadian Rotavirus Surveillance Through the Immunization Monitoring Program Active (IMPACT)

NCT01633190 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2021-03-22

No results posted yet for this study

Summary

* Rotavirus Hospital Admissions Surveillance
* Retrospective surveillance for 2010 and 2011 for hospital admissions in children aged 0 to 16 years due to rotavirus gastroenteritis will be completed by all centers of the IMPACT (Immunization Monitoring Program, ACTive) pediatric hospital network.
* Prospective surveillance of rotavirus-related admissions for children aged 0 to 16 years was conducted in 2012-20 inclusive and will be performed for an additional 2 years until the end of 2022 at all 12 sites. Surveillance methodology will continue using the same case-finding strategy and the same case report form as in past surveillance (Case reporting is done electronically.
* Emergency Department Burden of Disease Case finding for all-cause diarrheal illness using ICD codes was undertaken prospectively for 2012 to 2014 and will not continue in the years 2015-17 inclusive. Systematic stool sampling was carried out for cases of gastroenteritis in children \< 5 years of age presenting to the ED departments at the IMPACT hospitals in 2012 and 2013 and 5 of the 12 center hospitals in 2014. This component will not continue in to the 2015-17 protocol study years. However the admitted cases presenting to the IMPACT center hospitals with positive rotavirus will be reported and stool samples saved for genotyping at a later date.

Conditions

  • Viral Gastroenteritis Due to Rotavirus

Sponsors & Collaborators

  • Canadian Paediatric Society

    lead OTHER

Principal Investigators

  • Nicole Le Saux, MD · Children's Hospital of Eastern Ontario

Eligibility

Min Age
1 Minute
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01633190 on ClinicalTrials.gov